Background Assessing bleeding risk during the decision-making process of starting oral
anticoagulation (OAC) therapy in atrial fibrillation (AF) patients is essential. Several bleeding …

Background: Atrial fibrillation (Afib) patients are at an increased risk of stroke. Patients at
moderate to high risk of stroke typically receive antithrombotics, placing them at an …

Aims Bleeding risk assessment is recommended in guidelines for the management of atrial
fibrillation (AF). The HAS-BLED score was proposed prior to non-vitamin K antagonist oral …

Prevention of thromboembolism is the key priority in the management of patients with atrial
fibrillation (AF). Clinical decisions on antithrombotic management should be based on the …

Objective Balancing bleeding risk and stroke risk in patients with atrial fibrillation (AF) is a
common challenge. Though several bleeding risk scores exist, most have not included …

What is known and objective Bleeding risk scores (BRS s) aid in the assessment of oral
anticoagulant‐related bleeding risk in patients with atrial fibrillation. Ideally, the applicability …

Background Reducing major bleeding events is a challenge when managing
anticoagulation in patients with atrial fibrillation. This study evaluated the impact of …

Background Various bleeding risk scores have been proposed to assess the risk of bleeding
in patients with atrial fibrillation taking oral anticoagulants. Limited data are available with …

Abstract Background and Aims To construct a bleeding events prediction model of
nonvalvular atrial fibrillation (NVAF) patients receiving rivaroxaban. Methods We conducted …

BACKGROUND: Current clinical decision tools for assessing bleeding risk in individuals
with atrial fibrillation (AF) have limited performance and were developed for individuals …